Karen dos Santos Ferreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karen dos Santos Ferreira has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Ana Miriam Velly
Faculty of Dental Medicine and Oral Health Science, Jewish General Hospital/ McGill University, Montreal, Quebec, Canada
6 shared publications- Fabíola Dach
Ribeirão Preto Medical School, University of São Paulo
1 shared publication Harjot Dhillon
Department of Dentistry, Jewish General Hospital, Montreal, Quebec, Canada
1 shared publicationJose G. Speciali
Department of Neurology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo
1 shared publication
Latest Publications
- Open Access
- 28 July 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Gender-affirming hormone therapy and migraine: A brief evidence summary and proposal for a new diagnostic entity for ICHD-4
- 28 July 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Open AccessGender-affirming hormone therapy and migraine: A brief evidence summary and proposal for a new diagnostic entity for ICHD-4
- Open Access
- 19 August 2025
- Published by SAGE Publications in Cephalalgia
- Vol. 45 (8)
Acute confusional migraine: Proposal for inclusion in the International Classification of Headache Disorders – 4th edition (ICHD-4)
- 19 August 2025
- Published by SAGE Publications in Cephalalgia
- Vol. 45 (8)
Open AccessAcute confusional migraine: Proposal for inclusion in the International Classification of Headache Disorders – 4th edition (ICHD-4)
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2025 (1) , 5382669
Acute Confusional Migraine: Case Reports and Discussion as a Distinct Entity
Background: Acute confusional migraine (ACM) is a migraine variant manifesting with confusion, agitation, disorientation, altered mental status, and/or memory deficits. ACM has notably been excluded from the International Classification of Headache Disorders (ICHD‐3 β), despite previous literature describing 120 cases and proposing a standardized classification. Considering these findings, clinicians must be aware of this condition as it can be confounded with other serious health conditions (e.g., stroke, encephalitis, and epilepsy). Objective: Herein, we describe three cases with altered consciousness during a migraine attack, discussing diagnostic criteria, treatment, prognostic implications, and future perspectives. Results: The first case, an 18‐year‐old male, presented to the emergency room with migraine with visual aura, followed by confusion and torpor. After 24 h, he was completely recovered without deficits. In the second case, a 30‐year‐old woman in puerperium presented with a visual aura followed by headache, confusion, and disorientation. She recovered her conscience without deficits. The third patient, a 36‐year‐old woman, showed up in the emergency room presenting migraine, hemiplegia, and confusion. She recovered without deficits after 8 days. Finally, the genetic panel confirmed familial hemiplegic migraine (for the third patient). All the tests, including brain computed tomography (CT) scan, angioscan, brain magnetic resonance imaging (MRI), lumbar puncture (LP), and toxicological workup, had normal results for all three patients. They were treated for migraine with long‐term control. Conclusion: ACM is a significant condition that can be mistaken for other serious health issues. Health professionals need to be better informed about their diagnosis and management strategies. Therefore, we proposed criteria to include ACM in the ICHD‐3 β classification, and we emphasize the need for future studies to improve understanding and treatment of this condition.
- 1 January 2025
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2025 (1) , 5382669
Open AccessAcute Confusional Migraine: Case Reports and Discussion as a Distinct Entity
Background: Acute confusional migraine (ACM) is a migraine variant manifesting with confusion, agitation, disorientation, altered mental status, and/or memory deficits. ACM has notably been excluded from the International Classification of Headache Disorders (ICHD‐3 β), despite previous literature describing 120 cases and proposing a standardized classification. Considering these findings, clinicians must be aware of this condition as it can be confounded with other serious health conditions (e.g., stroke, encephalitis, and epilepsy). Objective: Herein, we describe three cases with altered consciousness during a migraine attack, discussing diagnostic criteria, treatment, prognostic implications, and future perspectives. Results: The first case, an 18‐year‐old male, presented to the emergency room with migraine with visual aura, followed by confusion and torpor. After 24 h, he was completely recovered without deficits. In the second case, a 30‐year‐old woman in puerperium presented with a visual aura followed by headache, confusion, and disorientation. She recovered her conscience without deficits. The third patient, a 36‐year‐old woman, showed up in the emergency room presenting migraine, hemiplegia, and confusion. She recovered without deficits after 8 days. Finally, the genetic panel confirmed familial hemiplegic migraine (for the third patient). All the tests, including brain computed tomography (CT) scan, angioscan, brain magnetic resonance imaging (MRI), lumbar puncture (LP), and toxicological workup, had normal results for all three patients. They were treated for migraine with long‐term control. Conclusion: ACM is a significant condition that can be mistaken for other serious health issues. Health professionals need to be better informed about their diagnosis and management strategies. Therefore, we proposed criteria to include ACM in the ICHD‐3 β classification, and we emphasize the need for future studies to improve understanding and treatment of this condition.
- Open Access
- 29 December 2023
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 81 (12) , 1169-1178
Treating myofascial pain with dry needling: a systematic review for the best evidence-based practices in low back pain
Background Myofascial pain syndrome (MPS) is a common source of pain in primary care or pain clinics. There are many different ways to manage and treat MPS, such as physical exercise, trigger points massage, and dry needling. Objective The objective of this overview is to highlight and discuss the evidence-based treatment of myofascial pain by dry needling in patients with low back pain. Methods A systematic review was made based on meta-analysis (MA) and randomized controlled trials (RCTs) related to dry needling treatment for myofascial pain in patients with lumbar pain, published from 2000 to 2023. Results A total of 509 records were identified at first. Seventy were published before 2000, so they were excluded. From the remaining 439 studies, ninety-two were RCTs or MA, of which 86 additional studies were excluded for the following reasons: not related to dry needling treatment (n = 79), not published in English (n = 4), duplicated (n = 1), project protocol (n = 1), and not related to myofascial pain (n = 1). So, this review was based on 4 RCTs and two MA. These studies compared dry needling efficacy to other treatments, such as acupuncture, sham dry needling, laser therapy, physical therapy, local anesthetic injection, ischemic compression, and neuroscience education. Despite outcomes and follow-up period varied between them, they showed that dry needling can decrease post-intervention pain intensity and pain disability. Conclusion Dry needling is an effective procedure for the treatment of myofascial pain in patients with acute and chronic low back pain. Further high-quality studies are needed to clarify the long-term outcomes.
- 29 December 2023
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 81 (12) , 1169-1178
Open AccessTreating myofascial pain with dry needling: a systematic review for the best evidence-based practices in low back pain
Background Myofascial pain syndrome (MPS) is a common source of pain in primary care or pain clinics. There are many different ways to manage and treat MPS, such as physical exercise, trigger points massage, and dry needling. Objective The objective of this overview is to highlight and discuss the evidence-based treatment of myofascial pain by dry needling in patients with low back pain. Methods A systematic review was made based on meta-analysis (MA) and randomized controlled trials (RCTs) related to dry needling treatment for myofascial pain in patients with lumbar pain, published from 2000 to 2023. Results A total of 509 records were identified at first. Seventy were published before 2000, so they were excluded. From the remaining 439 studies, ninety-two were RCTs or MA, of which 86 additional studies were excluded for the following reasons: not related to dry needling treatment (n = 79), not published in English (n = 4), duplicated (n = 1), project protocol (n = 1), and not related to myofascial pain (n = 1). So, this review was based on 4 RCTs and two MA. These studies compared dry needling efficacy to other treatments, such as acupuncture, sham dry needling, laser therapy, physical therapy, local anesthetic injection, ischemic compression, and neuroscience education. Despite outcomes and follow-up period varied between them, they showed that dry needling can decrease post-intervention pain intensity and pain disability. Conclusion Dry needling is an effective procedure for the treatment of myofascial pain in patients with acute and chronic low back pain. Further high-quality studies are needed to clarify the long-term outcomes.
- Open Access
- 29 June 2023
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 14 (6) , 217-221
Chronic Unilateral Headache Related to Scar Neuromas
Postcraniotomy and posttraumatic headaches can result in scars generating local pain or referred pain following a neuropathic pattern. One hypothesis is that the pain can be caused and maintained by scar neuromas, developed after the nerve injury during the surgical process or trauma. This study reports two patients with chronic unilateral headaches: the first one with a posttraumatic scar in the parietal region and the other with a postsurgical scar in the mastoid region. In both patients, the headache was ipsilateral to the scar, suggesting primary headaches (trigeminal autonomic cephalalgia (TAC), as hemicrania continua and chronic cluster headache). Pharmacological treatment for these conditions failed. Instead, there was complete remission of the headache with anesthetic blockade of scar neuromas (demonstrated by clinical examination in both patients). An active search for traumatic or nontraumatic scars is recommended in all patients with refractory unilateral headaches, and anesthetic blocks for scar neuromas can be effective in treating this pain. J Med Cases. 2023;14(6):217-221 doi: https://doi.org/10.14740/jmc4087
- 29 June 2023
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 14 (6) , 217-221
Open AccessChronic Unilateral Headache Related to Scar Neuromas
Postcraniotomy and posttraumatic headaches can result in scars generating local pain or referred pain following a neuropathic pattern. One hypothesis is that the pain can be caused and maintained by scar neuromas, developed after the nerve injury during the surgical process or trauma. This study reports two patients with chronic unilateral headaches: the first one with a posttraumatic scar in the parietal region and the other with a postsurgical scar in the mastoid region. In both patients, the headache was ipsilateral to the scar, suggesting primary headaches (trigeminal autonomic cephalalgia (TAC), as hemicrania continua and chronic cluster headache). Pharmacological treatment for these conditions failed. Instead, there was complete remission of the headache with anesthetic blockade of scar neuromas (demonstrated by clinical examination in both patients). An active search for traumatic or nontraumatic scars is recommended in all patients with refractory unilateral headaches, and anesthetic blocks for scar neuromas can be effective in treating this pain. J Med Cases. 2023;14(6):217-221 doi: https://doi.org/10.14740/jmc4087
- 1 August 2022
- Published by Wolters Kluwer Health in Pain
- Vol. 163 (8) , e966-e967
Cognitive decline over time in patients with chronic pain and headache: how can different outcomes be explained?
- 1 August 2022
- Published by Wolters Kluwer Health in Pain
- Vol. 163 (8) , e966-e967
Cognitive decline over time in patients with chronic pain and headache: how can different outcomes be explained?
- 3 July 2021
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 21 (7) , 817-831
The role of a potential biomarker in patients with migraine: review and new insights
The search for an ideal biomarker for migraine has persisted for a long time. There is plentiful evidence of potential biomarkers for migraine found in cerebrospinal fluid, blood and saliva.Herein,...
- 3 July 2021
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 21 (7) , 817-831
The role of a potential biomarker in patients with migraine: review and new insights
The search for an ideal biomarker for migraine has persisted for a long time. There is plentiful evidence of potential biomarkers for migraine found in cerebrospinal fluid, blood and saliva.Herein,...
- Open Access
- 1 January 2021
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 12 (5) , 202-204
Can Allodynia Predict Headache Related to Personal Protective Equipment for the Prevention of COVID-19?
Can Allodynia Predict Headache Related to Personal Protective Equipment for the Prevention of COVID-19?
- 1 January 2021
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 12 (5) , 202-204
Open AccessCan Allodynia Predict Headache Related to Personal Protective Equipment for the Prevention of COVID-19?
Can Allodynia Predict Headache Related to Personal Protective Equipment for the Prevention of COVID-19?